ORCL Cuts Jobs

Oracle Corp (NYSE: ORCL ) shares are trading lower Wednesday afternoon as investors digest workforce cuts tied to AI adoption. Oracle stock is feeling bearish pressure. Why is ORCL stock falling? What Is Driving Oracle’s Workforce Cuts?

On Tuesday, Sen. Elizabeth Warren warned that AI could eliminate millions of jobs, pointing to Oracle’s latest annual filing as a stark example. The database giant cut 21,000 employees over the past year, nearly 13% of its workforce, revealing that AI "adoption and deployment" fueled the reductions. Management further noted that additional workforce reductions could occur down the line.

This operational reset brought Oracle’s total headcount down to 141,000 full-time employees as of May 2026. While leadership cautioned that the layoffs could prove "disruptive" by risking lower productivity and a loss of institutional knowledge, the market is balancing these cuts against Oracle’s aggressive expansion goals. Specifically, investors are weighing a January initiative to raise $50 billion in debt and equity to fund accelerating AI infrastructure. This aggressive balancing act comes against a backdrop of soaring corporate expenses.

7 billion. Ultimately, this combination keeps traders intensely focused on how quickly Oracle’s internal efficiency gains can offset its massive AI buildout spending. Oracle Health Partners With Theator To Bring AI Into The Operating Room On Wednesday, the tech giant announced a collaboration between Oracle Health and surgical AI pioneer Theator to deploy AI-powered intelligence solutions to healthcare providers across the United States. Powered by Oracle Cloud Infrastructure, the system automatically translates live surgical video into structured electronic health records to eliminate manual dictation, reduce coding gaps, and improve billing accuracy.

For investors, this practical roll-out serves as a timely reminder of Oracle’s ability to monetize its AI ecosystem in high-stakes industries like healthcare. 8% below its 200-day SMA and 17% below its 50-day SMA. 4% below the 100-day SMA, making that zone a key "make-or-break" area if buyers try to stabilize the tape. Momentum is also leaning bearish: MACD is below its signal line and the histogram is negative, which suggests upside pressure is fading versus the prior upswing unless it can reclaim that baseline.

The death cross that formed in January (50-day SMA below the 200-day SMA) remains an overhang, even though the 20-day SMA is still above the 50-day SMA (a shorter-term bullish crossover that hasn’t translated into sustained price strength). 64. 2) — The stock is lagging recently, which lines up with price sitting well below key long-term moving averages. 13) — The valuation reads expensive versus peers, leaving less room for error if growth expectations cool.

73) — The market is still crediting Oracle with a strong growth runway, likely tied to cloud and AI-related demand. The Verdict: Oracle’s Edge signal reveals a growth-heavy profile with weak momentum and weak value characteristics. 00 support zone is the nearby line that matters most. 94 at the time of publication on Wednesday, according to Pro data.

Read Also: Silver’s 50% Crash Reaches 'Oversold' Levels: Should You Buy The Dip? Image: Shutterstock